STING activation reduces graft-versus-host disease in mouse model
A team has shown that STING activation is a new molecular target in the fight against graft-versus-host disease (GVHD).
List view / Grid view
A team has shown that STING activation is a new molecular target in the fight against graft-versus-host disease (GVHD).
The vitamin K-based drug has a unique structure which researchers believe makes it effective in controlling even medication-resistant seizures.
Administering a novel complement protein blocker (B4Crry) alongside reperfusion therapy improved cognitive and motor recovery in a model of ischemic stroke.
A study has revealed that a sponge endemic to an Indonesian bay produces manzamine A, a compound which inhibits proteins in cervical cancers.
Researchers have found that PGE2, a signalling molecule involved in inflammation, promotes colorectal cancer progression through a microRNA and targeting that microRNA could have therapeutic potential.
A new study into the enzyme Cdc34 may make it possible to target the enzyme specifically to develop new cancer therapeutics.
Scientists have discovered a way to improve immune-based treatments by modulating T cells.
Scientists in the U.S. have reported findings about the mechanisms that contribute to the experience of weaker bones with age.
Breakthrough research has uncovered an unexpected mechanism that underlies cardiomyopathy in DMD...